Today's Brokerage Rating: Geron Corporation (GERN), AmerisourceBergen Corporation

Share

AmerisourceBergen Corporation (NYSE:ABC) ended its day at $75.40 with the rising stream of 0.53% and its total traded volume was 2.89 million shares more than the average volume. The consensus mean EPS for the current quarter is at $-0.04 derived from a total of 3 estimates from the analysts who have weighed in on projected earnings. The biopharmaceutical company reported ($0.02) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.06) by $0.04.

Recent insider trends for Geron Corporation (NASDAQ:GERN) have caught the attention of investors.

In the most updated research from a number of analysts on Wall Street, the company gets 1 Buys and 0 Sell among 4 analysts. Stifel Nicolaus now has a $2.50 price objective on the biopharmaceutical company's stock.

Geron Corporation (GERN) has risen 4.28% since then. Finally, Zacks Investment Research raised shares of Geron Corp. from a "hold" rating to a "strong-buy" rating and set a $3.00 price target on the stock in a research note on Friday, August 5th.

Taking a broader look at the analyst consensus, according to 2 analysts Geron Corporation (NASDAQ:GERN)'s price will reach at $3.75 during 52 weeks. This works out to a net increase in ownership of 2.06 million shares, and suggests that institutions are feeling bullish about the stock. For the full year, analysts expect earnings to decline -10.53% yoy to -$0.17. Analyzing the last five market sessions, the stock was able to report -5.34% losses, thus going down by -17.79%, compared with its 200-day moving average of $2.44. BTIG Research reaffirmed a "neutral" rating on shares of Geron Corp.in a research note on Tuesday, September 20th. Needham & Company LLC restated a "hold" rating on shares of Geron Corporation in a research report on Friday, November 3rd. Revenue during the quarter was $507.84 million, representing -4% growth from $529.5 million in year-ago quarter. If you are reading this article on another publication, it was illegally copied and reposted in violation of global copyright and trademark legislation.

COPYRIGHT VIOLATION NOTICE: "Favorable Media Coverage Somewhat Unlikely to Affect Geron Corporation (GERN) Stock Price" was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2017/11/13/geron-corporations-gern-hold-rating-reaffirmed-at-stifel-nicolaus.html. Russell Investments Group Ltd. bought a new position in shares of Geron Corporation in the second quarter worth about $114,000. Tudor Investment Corp ET AL boosted its holdings in shares of Geron Corporation by 12.1% in the 1st quarter. IHT Wealth Management LLC bought a new position in shares of Geron Corporation in the second quarter worth about $122,000. Vanguard Group Inc. now owns 6,296,230 shares of the biopharmaceutical company's stock valued at $16,874,000 after buying an additional 465,626 shares in the last quarter. Parametric Portfolio Associates LLC raised its stake in shares of Geron Corporation by 59.4% in the second quarter. Tudor Investment Corp ET AL now owns 52,369 shares of the biopharmaceutical company's stock worth $119,000 after acquiring an additional 5,669 shares in the last quarter.

Currently Geron Corporation (NASDAQ:GERN)'s shares owned by insiders are 0.1%, whereas shares owned by institutional owners are 39.2%. Using its nucleic acid chemistry, Geron designed Imetelstat to be an oligonucleotide that binds with high affinity to the ribonucleic acid (RNA) template of telomerase, thereby directly inhibiting telomerase activity.

Share

Advertisement

Related Posts

Per person disease burden drops by 36 per cent
Urbanization and aging have led to increasing poor health conditions related to non-communicable diseases in all states. More data are available through IHME's data visualization at: https://vizhub.healthdata.org/gbd-compare/india .

Microsoft Corporation (MSFT) Insider Sells 15000 Shares of Stock
Great West Life Assurance Can holds 0.05% or 28,993 shares. 1832 Asset Management LP holds 8.74M shares or 2.73% of its portfolio. It worsened, as 42 investors sold FOX shares while 120 reduced holdings. 59 funds opened positions while 106 raised stakes.

Stock grabbing Attention: The Hartford Financial Services Group, Inc. (HIG)
Palisade Capital Management Llc increased Herbalife Ltd (Prn) stake by 2.14M shares to 6.44 million valued at $6.71M in 2017Q2. Intrust Bankshares Na holds 0.27% of its portfolio in Hartford Financial Services Group Inc (NYSE: HIG ) for 14,954 shares.

The Short Interest in United States Steel Corp. (X) Drops By 8.1%
Jennison Associates LLC acquired a new stake in United States Steel Corporation in the 2nd quarter worth about $20,786,000. Analysts believe that the company has the potential to earn average revenue of $1.44 Billion for the current quarter.

Russian FM says Iran can legitimately stay in Syria
Gadi Eisenkot secretly flew to Brussels on Friday where he met with met with the head of the US Army's European Command Gen. The presence of Iran in Syria is legitimate, Lavrov was quoted as saying by another agency, Interfax.

Lookout for Price Target? SunTrust Banks, Inc. (STI), Cree, Inc. (CREE)
Finally, Ballentine Partners LLC purchased a new stake in SunTrust Banks during the 1st quarter valued at approximately $275,000. Following the sale, the insider now owns 239,652 shares of the company's stock, valued at approximately $11,000,026.80.

Turkey's Erdogan says he will discuss Gulf crisis in Kuwait
Qatar, the world's largest exporter of liquified natural gas, denies the accusations. The report did not give further detail on the agreements.

Draxler rules out PSG exit
Julian Draxler says he is not interested in a mid-season move to Bayern Munich, despite finding time in Paris Saint-Germain's starting XI tough to come by.

Intuit Inc. (INTU) Now Covered by Analysts at UBS AG
Godshalk Welsh Capital Mngmt invested 1.81% of its portfolio in Intuit Inc. (NASDAQ:INTU) rating on Thursday, September 21. The United Kingdom-based Wellcome Trust Ltd (The) As Trustee Of The Wellcome Trust has invested 6.41% in the stock.

Meet Lebanese-origin Alex Azar, Trump's pick for health secretary
Azar served as the president of the American division of pharmaceutical giant Eli Lilly from 2012 until January of this year. Bush's first term, which was his first healthcare-focused professional role.

© 2015 ExpressNewsline. All Rights reserved.